相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research
Jan Van Deun et al.
NATURE METHODS (2017)
Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma
Abhishek D. Garg et al.
ONCOIMMUNOLOGY (2017)
Pathogen response-like recruitment and activation of neutrophils by sterile immunogenic dying cells drives neutrophil-mediated residual cell killing
Abhishek D. Garg et al.
CELL DEATH AND DIFFERENTIATION (2017)
Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells
Gerty Schreibelt et al.
CLINICAL CANCER RESEARCH (2016)
Myeloid cells in the tumor microenvironment: Role of adenosine
Silvana Morello et al.
ONCOIMMUNOLOGY (2016)
Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy
Kristina Iribarren et al.
ONCOIMMUNOLOGY (2016)
Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma
Lien Vandenberk et al.
ONCOIMMUNOLOGY (2016)
Human mesothelioma induces defects in dendritic cell numbers and antigen-processing function which predict survival outcomes
Scott M. J. Cornwall et al.
ONCOIMMUNOLOGY (2016)
Long-lasting multifunctional CD8+ T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccination
Florian Wimmers et al.
ONCOIMMUNOLOGY (2016)
The extent to which melanoma alters tissue-resident dendritic cell function correlates with tumorigenicity
Kristian Michael Hargadon
ONCOIMMUNOLOGY (2016)
Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysis
Abhishek D. Garg et al.
ONCOIMMUNOLOGY (2016)
PD-1 expression conditions T cell avidity within an antigen-specific repertoire
Sylvain Simon et al.
ONCOIMMUNOLOGY (2016)
Perspectives on sipuleucel-T: Its role in the prostate cancer treatment paradigm
James L. Gulley et al.
ONCOIMMUNOLOGY (2016)
Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?
Laura Rosa Brunet et al.
ONCOIMMUNOLOGY (2016)
Trial Watch-Immunostimulation with cytokines in cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2016)
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
Benjamin Besse et al.
ONCOIMMUNOLOGY (2016)
Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination
Kalijn F. Bol et al.
ONCOIMMUNOLOGY (2016)
Transplantation and Damage-Associated Molecular Patterns (DAMPs)
W. G. Land et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
DAMP-Induced Allograft and Tumor Rejection: The Circle Is Closing
W. G. Land et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
The Use of Toll-like Receptor 4 Agonist to Reshape the Immune Signature in Ovarian Cancer
Eva Vindevogel et al.
ANTICANCER RESEARCH (2016)
In Vitro Generation of Murine Dendritic Cells for Cancer Immunotherapy: An Optimized Protocol
Thais Baert et al.
ANTICANCER RESEARCH (2016)
Local delivery of CpG-B and GM-CSF induces concerted activation of effector and regulatory T cells in the human melanoma sentinel lymph node
Mari F. C. M. van den Hout et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor-dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2
Julia M. Greene et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Microbiome and Anticancer Immunosurveillance
Laurence Zitvogel et al.
CELL (2016)
Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation
A. D. Garg et al.
CELL DEATH AND DIFFERENTIATION (2016)
The Safety and Immunological Effects of rAd5-EBV-LMP2 Vaccine in Nasopharyngeal Carcinoma Patients: A Phase I Clinical Trial and Two-Year Follow-Up
Yongfeng Si et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2016)
Dendritic Cell-Based Immunotherapy: State of the Art and Beyond
Kalijn F. Bol et al.
CLINICAL CANCER RESEARCH (2016)
Combination of cytokine-induced killer and dendritic cells pulsed with antigenic α-1,3-galactosyl epitope-enhanced lymphoma cell membrane for effective B-cell lymphoma immunotherapy
Ying Qiu et al.
CYTOTHERAPY (2016)
In situ vaccination for the treatment of cancer
Linda Hammerich et al.
IMMUNOTHERAPY (2016)
Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
Sofie Wilgenhof et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Feasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer
Luping Zhang et al.
RADIATION ONCOLOGY (2016)
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma
Abhishek D. Garg et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
The Human Vaccines Project: A roadmap for cancer vaccine development
Pedro Romero et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity
Damya Laoui et al.
NATURE COMMUNICATIONS (2016)
TCR Sequencing Can Identify and Track Glioma-Infiltrating T Cells after DC Vaccination
Melody S. Hsu et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Immune checkpoint blockade reveals the stimulatory capacity of tumor-associated CD103+ dendritic cells in late-stage ovarian cancer
Dallas B. Flies et al.
ONCOIMMUNOLOGY (2016)
Prioritization schema for immunotherapy clinical trials in glioblastoma
Tiffany R. Hodges et al.
ONCOIMMUNOLOGY (2016)
CMRF-56+ blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses
Phillip D. Fromm et al.
ONCOIMMUNOLOGY (2016)
Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death
Stefania Di Blasio et al.
ONCOIMMUNOLOGY (2016)
The dual role of tumor lymphatic vessels in dissemination of metastases and immune response development
Joanna Stachura et al.
ONCOIMMUNOLOGY (2016)
mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma
Troels Holz Borch et al.
ONCOIMMUNOLOGY (2016)
Chemotherapy and immunotherapy: A close interplay to fight cancer?
Aurelie Hanoteau et al.
ONCOIMMUNOLOGY (2016)
Ipilimumab reshapes T cell memory subsets in melanoma patients with clinical response
Joana Felix et al.
ONCOIMMUNOLOGY (2016)
Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients
Steve Boudewijns et al.
ONCOIMMUNOLOGY (2016)
Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinoma
Isabel Poschke et al.
ONCOIMMUNOLOGY (2016)
Advancing targeted co-stimulation with antibody-fusion proteins by introducing TNF superfamily members in a single-chain format
Sina Fellermeier et al.
OncoImmunology (2016)
Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells
Jon Amund Kyte et al.
ONCOIMMUNOLOGY (2016)
Calreticulin expression: Interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer
Gautier Stoll et al.
ONCOIMMUNOLOGY (2016)
Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity
Jasper J. P. van Beek et al.
ONCOIMMUNOLOGY (2016)
Antigen-Loaded Upconversion Nanoparticles for Dendritic Cell Stimulation, Tracking, and Vaccination in Dendritic Cell-Based Immunotherapy
Jian Xiang et al.
ACS NANO (2015)
Survivin and PSMA Loaded Dendritic Cell Vaccine for the Treatment of Prostate Cancer
Hai-Bo Xi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
Jeong-Hoon Lee et al.
BRITISH JOURNAL OF CANCER (2015)
Dendritic Versus Tumor Cell Presentation of Autologous Tumor Antigens for Active Specific Immunotherapy in Metastatic Melanoma: Impact on Long-Term Survival by Extent of Disease at the Time of Treatment
Robert O. Dillman et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2015)
A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma
Deepa K. Krishnadas et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial
Yoshinari Maeda et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions
Yannick Willemen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Cytokine induced killer cell-based immunotherapies in patients with different stages of renal cell carcinoma
Xuan Zhao et al.
CANCER LETTERS (2015)
Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine
Yasuhiko Ohshio et al.
CANCER SCIENCE (2015)
Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer
Shuhei Mayanagi et al.
CANCER SCIENCE (2015)
Safety and tolerability of allogeneic dendritic cell vaccination with induction of Wilms tumor 1-specific T cells in a pediatric donor and pediatric patient with relapsed leukemia: a case report and review of the literature
Shoji Saito et al.
CYTOTHERAPY (2015)
Efficacy of dendritic cell-cytokine-induced killer immunotherapy plus intensity-modulated radiation therapy in treating elderly patients with esophageal carcinoma
L. Yan et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Dendritic cell immunotherapy combined with cytokine-induced killer cells promotes skewing toward Th2 cytokine profile in patients with metastatic non-small cell lung cancer
Peng Zhao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Immune responses in patients with esophageal cancer treated with SART1 peptide-pulsed dendritic cell vaccine
Miwako Narita et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
A Phase I Clinical Trial of CD1c (BDCA-1)+ Dendritic Cells Pulsed With HLA-A*0201 Peptides for Immunotherapy of Metastatic Hormone Refractory Prostate Cancer
Rebecca L. Prue et al.
JOURNAL OF IMMUNOTHERAPY (2015)
Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma
Keiichi Sakai et al.
JOURNAL OF NEUROSURGERY (2015)
Phase I Trial of Active Specific Immunotherapy with Autologous Dendritic Cells Pulsed With Autologous Irradiated Tumor Stem Cells in Hepatitis B- positive Patients with Hepatocellular Carcinoma
Xiaojin Wang et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting
Evan J. Lipson et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma
Carmela Rozera et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity
Yaron Carmi et al.
NATURE (2015)
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
Duane A. Mitchell et al.
NATURE (2015)
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Beatriz M. Carreno et al.
SCIENCE (2015)
Study on the Treatment of metastatic castration resistant Prostate Cancer
H. Rexer
UROLOGE (2015)
Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy
Shintaro Tsukinaga et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Study on the Treatment of metastatic castration resistant Prostate Cancer
H. Rexer
UROLOGE (2015)
Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies
Gautier Stoll et al.
ONCOTARGET (2015)
Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal
Abhishek D. Garg et al.
ONCOTARGET (2015)
Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer
Michal Podrazil et al.
ONCOTARGET (2015)
Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141+ Dendritic Cells and Enhanced Cross-Presentation
Berbel J. R. Sluijter et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Corrigendum: “Combinatorial Strategies for the Induction of Immunogenic Cell Deathâ€
Lucillia Bezu et al.
Frontiers in Immunology (2015)
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
Abhishek D. Garg et al.
FRONTIERS IN IMMUNOLOGY (2015)
Prognostic and predictive value of DAMPs and DAMP-associated processes in cancer
Jitka Fucikova et al.
FRONTIERS IN IMMUNOLOGY (2015)
Trial Watch: Adoptive cell transfer for oncological indications
Fernando Aranda et al.
ONCOIMMUNOLOGY (2015)
High-throughput monitoring of human tumor-specific T-cell responses with large peptide pools
Mathieu F. Chevalier et al.
ONCOIMMUNOLOGY (2015)
B cells drive Th2 responses by instructing human dendritic cell maturation
Mohan S. Maddur et al.
ONCOIMMUNOLOGY (2015)
Rapid generation of NY-ESO-1-specific CD4+ THELPER1 cells for adoptive T-cell therapy
Simone Kayser et al.
ONCOIMMUNOLOGY (2015)
Intratumoral delivery of mRNA: Overcoming obstacles for effective immunotherapy
Kevin Van der Jeught et al.
ONCOIMMUNOLOGY (2015)
Tumors induce immune tolerance through activation of beta-catenin/TCF4 signaling in dendritic cells: A novel therapeutic target for cancer immunotherapy
Amol Suryawanshi et al.
ONCOIMMUNOLOGY (2015)
Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy
Heleen H. Van Acker et al.
ONCOIMMUNOLOGY (2015)
Trial watch: Tumor-targeting monoclonal antibodies for oncological indications
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2015)
Trial Watch: Peptide-based anticancer vaccines
Jonathan Pol et al.
ONCOIMMUNOLOGY (2015)
Cancer stem cell vaccine inhibits metastases of primary tumors and induces humoral immune responses against cancer stem cells
Lin Lu et al.
ONCOIMMUNOLOGY (2015)
Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients
Kalijn F. Bol et al.
ONCOIMMUNOLOGY (2015)
Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis
Marieta Toma et al.
ONCOIMMUNOLOGY (2015)
Controlling T cell senescence in the tumor microenvironment for tumor immunotherapy
Jian Ye et al.
ONCOIMMUNOLOGY (2015)
Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphoma
Arne Kolstad et al.
BLOOD (2015)
Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer
Hideki Kimura et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastases
Sofie Wilgenhof et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Therapeutic DC vaccination with IL-2 as a consolidation therapy for ovarian cancer patients: a phase I/II trial
Soyoung Baek et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme
Martin K. Hunn et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Immunotherapy of uveal melanoma: vaccination against cancer. Multicenter adjuvant phase 3 vaccination study using dendritic cells laden with tumor RNA for large newly diagnosed uveal melanoma
B. Schuler-Thurner et al.
OPHTHALMOLOGE (2015)
Sequential infusion of donor-derived dendritic cells with donor lymphocyte infusion for relapsed hematologic cancers after allogeneic hematopoietic stem cell transplantation
Vincent T. Ho et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients
Kalijn F. Bol et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2014)
The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity
Kea Martin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma
Isabel Poschke et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Interleukin 12: still a promising candidate for tumor immunotherapy?
Witold Lasek et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Induction and Activation of Human Th17 by Targeting Antigens to Dendritic Cells via Dectin-1
Dorothee Duluc et al.
JOURNAL OF IMMUNOLOGY (2014)
Enhancement of Tumor-Specific T Cell-Mediated Immunity in Dendritic Cell-Based Vaccines by Mycobacterium tuberculosis Heat Shock Protein X
In Duk Jung et al.
JOURNAL OF IMMUNOLOGY (2014)
Clinical use of dendritic cells for cancer therapy
Sebastien Anguille et al.
LANCET ONCOLOGY (2014)
Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI
Eric T. Ahrens et al.
MAGNETIC RESONANCE IN MEDICINE (2014)
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu et al.
NATURE MEDICINE (2014)
Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
Madhav V. Dhodapkar et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Classification of current anticancer immunotherapies
Lorenzo Galluzzi et al.
ONCOTARGET (2014)
Trial watch: Dendritic cell-based anticancer therapy
Norma Bloy et al.
ONCOIMMUNOLOGY (2014)
The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
Miriam Merad et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Cancer immunogenicity, danger signals, and DAMPs: What, when, and how?
Abhishek D. Garg et al.
BIOFACTORS (2013)
Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients
Jurjen Tel et al.
CANCER RESEARCH (2013)
Human CD1c+ Dendritic Cells Drive the Differentiation of CD103+ CD8+ Mucosal Effector T Cells via the Cytokine TGF-β
Chun I. Yu et al.
IMMUNITY (2013)
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Karolina Palucka et al.
IMMUNITY (2013)
Specialized role of migratory dendritic cells in peripheral tolerance induction
Juliana Idoyaga et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity
Beatriz M. Carreno et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Mucosal Imprinting of Vaccine-Induced CD8+ T Cells Is Crucial to Inhibit the Growth of Mucosal Tumors
Federico Sandoval et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
RNA pulsed dendritic cells: An approach for cancer immunotherapy
Neeraj Kumar Garg et al.
VACCINE (2013)
Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity
Aleksandra M. Dudek et al.
FRONTIERS IN IMMUNOLOGY (2013)
Targeting Antigens to Dendritic Cell Receptors for Vaccine Development
Vasso Apostolopoulos et al.
JOURNAL OF DRUG DELIVERY (2013)
Decisions About Dendritic Cells: Past, Present, and Future
Ralph M. Steinman
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN
Luis J. Cruz et al.
BIOMATERIALS (2012)
The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells
Gerty Schreibelt et al.
BLOOD (2012)
Antibodies and carbohydrate ligands binding to DC-SIGN differentially modulate receptor trafficking
Paul J. Tacken et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells
Dapeng Li et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Phase I trial of preoperative intratumoral injection of immature dendritic cells and OK-432 for resectable pancreatic cancer patients
Hisahito Endo et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2012)
Cross-presentation by dendritic cells
Olivier P. Joffre et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation
Paul J. Tacken et al.
BLOOD (2011)
Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity
Paul J. Tacken et al.
BLOOD (2011)
Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response
Jitka Fucikova et al.
CANCER RESEARCH (2011)
Potent Antitumor Immunity Generated by a CD40-Targeted Adenoviral Vaccine
Basav N. Hangalapura et al.
CANCER RESEARCH (2011)
Ralph M. Steinman 1943-2011 Obituary
Antonio Lanzavecchia et al.
CELL (2011)
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2011)
Dendritic cell-tumor cell hybrids and immunotherapy: what's next?
Dominique Cathelin et al.
CYTOTHERAPY (2011)
Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials
Jitka Fucikova et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Ralph Steinman (1943-2011) OBITUARY
Michel C. Nussenzweig et al.
NATURE (2011)
Ralph M. Steinman (1943-2011)
Ira Mellman et al.
SCIENCE (2011)
Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR
Eynav Klechevsky et al.
BLOOD (2010)
Dendritic Cell-Derived Exosomes for Cancer Immunotherapy: What's Next?
Sophie Viaud et al.
CANCER RESEARCH (2010)
The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8α+ dendritic cells
Karine Crozat et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
Sarah L. Jongbloed et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells
Annabell Bachem et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells
Lionel Franz Poulin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Sipuleucel-T
Celestia S. Higano et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo
Erin E. Thacker et al.
VACCINE (2009)
Functional specializations of human epidermal langerhans cells and CD14+ dermal dendritic cells
Eynav Klechevsky et al.
IMMUNITY (2008)
Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients
Nadege Bercovici et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Engineered lentivector targeting of dendritic cells for in vivo immunization
Lili Yang et al.
NATURE BIOTECHNOLOGY (2008)
Dendritic cell subsets in health and disease
Hideki Ueno et al.
IMMUNOLOGICAL REVIEWS (2007)
Dendritic-cell immunotherapy:: from ex vivo loading to in vivo targeting
Paul J. Tacken et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Taking dendritic cells into medicine
Ralph M. Steinman et al.
NATURE (2007)
Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system
Pedro Berraondo et al.
CANCER RESEARCH (2007)
B subunit of Shiga toxin-based Vaccines synergize with α-galactosylceramide to break tolerance against self antigen and elicit antiviral immunity
Olivier Adotevi et al.
JOURNAL OF IMMUNOLOGY (2007)
Enhanced delivery of immunoliposomes to human dendritic cells by targeting the multilectin receptor DEC-205
Ali Badiee et al.
VACCINE (2007)
DC-based cancer vaccines
Eli Gilboa
JOURNAL OF CLINICAL INVESTIGATION (2007)
Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion
Brian J. Czerniecki et al.
CANCER RESEARCH (2007)
Differential antigen processing by dendritic cell subsets in vivo
Diana Dudziak et al.
SCIENCE (2007)
Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells
Jinwei Hu et al.
CANCER RESEARCH (2006)
A biophysical approach to the optimisation of dendritic-tumour cell electrofusion
Vladimir L. Sukhorukov et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity
Benoit Vingert et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell priming
F Errington et al.
GENE THERAPY (2006)
Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody
PJ Tacken et al.
BLOOD (2005)
High efficiency transduction of dendritic cells by adenoviral vectors targeted to DC-SIGN
N Korokhov et al.
CANCER BIOLOGY & THERAPY (2005)
Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity
SC Yang et al.
CLINICAL CANCER RESEARCH (2004)
In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination
LC Bonifaz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Antitumor effects of vaccine consisting of dendritic cells pulsed with tumor RNA from gastric cancer
Bing-Ya Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
Induction of cytotoxic T lymphocytes by dendritic cells pulsed with murine leukemic cell RNA
CW Jung et al.
AMERICAN JOURNAL OF HEMATOLOGY (2004)
Targeting dendritic cells with antigen-containing liposomes: A highly effective procedure for induction of antitumor immunity and for tumor immunotherapy
CL van Broekhoven et al.
CANCER RESEARCH (2004)
Apoptotic tumor cells are superior to tumor cell lysate, and tumor cell RNA in induction of autologous T cell response in B-CLL
P Kokhaei et al.
LEUKEMIA (2004)
Electrofusion of syngeneic dendritic cells and tumor generates potent therapeutic vaccine
J Kjaergaard et al.
CELLULAR IMMUNOLOGY (2003)
Enhancement of antigen-presenting capacity and antitumor immunity of dendritic cells pulsed with autologous tumor-derived RNA in mice
T Minami et al.
JOURNAL OF IMMUNOTHERAPY (2003)
Generation of cytotoxic responses in mice and human individuals against hematological malignancies using survivin-RNA-transfected dendritic cells
M Zeis et al.
JOURNAL OF IMMUNOLOGY (2003)
Dendritic cells loaded with apoptotic tumour cells induce a stronger T-cell response than dendritic cell-tumour hybrids in B-CLL
P Kokhaei et al.
LEUKEMIA (2003)
Liposomal delivery of antigen to human dendritic cells
MJ Copland et al.
VACCINE (2003)
Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance
L Bonifaz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Therapeutic immune response induced by electrofusion of dendritic and tumor cells
H Tanaka et al.
CELLULAR IMMUNOLOGY (2002)
Efficient genetic modification of murine dendritic cells by electroporation with mRNA
S Van Meirvenne et al.
CANCER GENE THERAPY (2002)
The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor
M Gilliet et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Electrofusion of a weakly immunogenic neuroblastoma with dendritic cells produces a tumor vaccine
RJ Orentas et al.
CELLULAR IMMUNOLOGY (2001)
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo
D Hawiger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells
Z Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki Forest virus-mediated complementary DNA
R Yamanaka et al.
JOURNAL OF NEUROSURGERY (2001)
Efficient nonviral transfection of dendritic cells and their use for in vivo immunization
AS Irvine et al.
NATURE BIOTECHNOLOGY (2000)
Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA
S Koido et al.
JOURNAL OF IMMUNOLOGY (2000)
Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent THI polarization
M Cella et al.
NATURE IMMUNOLOGY (2000)
The B subunit of shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens
N Haicheur et al.
JOURNAL OF IMMUNOLOGY (2000)
Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines
C Klein et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
SK Nair et al.
NATURE MEDICINE (2000)
Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells
A Ribas et al.
JOURNAL OF IMMUNOTHERAPY (2000)
分享论文
